Invention Grant
- Patent Title: Mass spectrometry assay for congenital adrenal hyperplasia
-
Application No.: US16588806Application Date: 2019-09-30
-
Publication No.: US10697980B2Publication Date: 2020-06-30
- Inventor: Amit Ghoshal , Nigel J. Clarke , Mildred M. Goldman
- Applicant: Quest Diagnostics Investments Incorporated
- Applicant Address: US DE Wilmington
- Assignee: Quest Diagnostics Investments Incorporated
- Current Assignee: Quest Diagnostics Investments Incorporated
- Current Assignee Address: US DE Wilmington
- Agency: Quest Diagnostics, Inc.
- Main IPC: H01J49/26
- IPC: H01J49/26 ; B01D59/44 ; G01N33/74 ; G01N33/68 ; H01J49/00 ; G01N30/72 ; H01J49/16 ; C12Q1/6872

Abstract:
Methods are provided for detecting the amount of one or more CAH panel analytes (i.e., pregnenolone, 17-OH pregnenolone, progesterone, 17-OH progesterone, dehydroepiandrosterone (DHEA), androstenedione, testosterone, deoxycorticosterone, 11-deoxycortisol, and cortisol) in a sample by mass spectrometry. The methods generally involve ionizing one or more CAH panel analytes in a sample and quantifying the generated ions to determine the amount of one or more CAH panel analytes in the sample. In methods where amounts of multiple CAH panel analytes are detected, the amounts of multiple analytes are detected in the same sample injection.
Public/Granted literature
- US20200057080A1 MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA Public/Granted day:2020-02-20
Information query